Well let’s just hope the CEO’s confidence is based on more than hubris. I don’t think a couple of wealthy people paying out of their own pocket would satisfy the revenue expectations he set during the presentation. I’m taking a glass half full approach and assuming the negotiations around reimbursement justify his confidence.
Based on your experience what’s the lead time between getting reimbursement approval and treating patient’s?
Ann: Investor Update, page-33
-
- There are more pages in this discussion • 63 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.6¢ |
Change
0.001(20.0%) |
Mkt cap ! $19.99M | |||
| Open | High | Low | Value | Volume |
| 0.5¢ | 0.6¢ | 0.5¢ | $24.67K | 4.285M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 1800000 | 0.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.6¢ | 16832747 | 23 |
View Market Depth
| Last trade - 16.10pm 20/06/2024 (20 minute delay) ? |
| OSL (ASX) Chart |